Press release content from Globe Newswire. The AP news staff was not involved in its creation. Emerald Health Pharmaceuticals Demonstrates Potential Disease-Modifying Activity of Novel ... Emerald Health PharmaceuticalsFebruary 9, 2021 GMT Data published in peer-reviewed journal, Molecular and Cellular Neuroscience show neuroprotective and neurogenic activity of proprietary product candidate, EHP-102 SAN DIEGO, CA, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP or the Company), a clinical-stage biotechnology company developing a new class of medicines to treat neur...